Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRISPR Therapeutics
Biotech
FDA reveals 2nd round of 'national priority' voucher winners
The program is designed to cut the agency's typical 10- to 12-month review timeline down to just one or two months.
Darren Incorvaia
Nov 6, 2025 3:12pm
CRISPR Tx, Sirius pen collab with a focus on thrombotic disease
May 20, 2025 3:59am
Appeals court reignites row over CRISPR discovery
May 13, 2025 8:00am
CRISPR Tx sees 80% fall in LDL, triglycerides after in vivo edit
May 7, 2025 10:00am
Yet another exec departs CRISPR Tx—Chutes & Ladders
Mar 28, 2025 8:30am
RFK Jr. will divest interests in biotechs if HHS role confirmed
Jan 22, 2025 1:37pm
